Filing Flows

Filing Flows › Arteris (AIP) › Q2 2026 › vs Q2 2025

Arteris (AIP) Q2 2026 vs Q2 2025 (year over year)

Arteris's revenue rose $7.6M (+46%) from $16.5M in Q2 2025 to $24.1M in Q2 2026. The biggest changes: Licensing, support and maintenance +$5.7M (+38%); Professional services and other +$1.2M (101×); Variable royalties +$701K (+50%).

Arteris, Q2 2026: revenue $24.1M (+46% year over year), operating margin -57.6%, net loss $14.1M, operating cash flow $9.2M. The chart draws each line against Q2 2025, the increases inside each band.

Arteris: what changed, Q2 2026 vs Q2 2025Arteris: what changed, Q2 2026 vs Q2 2025Operating cash sources$16.6MWorking capital & other$14.1MOperating costs$13.3MCosts & expenses$13.1MOperating cash flow$11.7MLicensing, support and mainte…$5.7MNet loss$4.9MNet loss absorbed$4.9MResearch & development$4.6MSales & marketing$3.1M

Every line

LineQ2 2026Q2 2025Change%
Licensing, support and maintenance$20.8M$15.1M$5.7M+38%
Variable royalties$2.1M$1.4M$701K+50%
Professional services and other$1.2M$12K$1.2M101×
Revenue$24.1M$16.5M$7.6M+46%
Other income, net$540K−$36K$576K—
Net loss$14.1M$9.1M$4.9M+54%
Costs & expenses$38.7M$25.6M$13.1M+51%
Operating costs$38.0M$24.8M$13.3M+54%
Income tax$697K$846K−$149K-18%
Cost of revenue$3.6M$1.7M$1.9M+107%
Research & development$16.8M$12.2M$4.6M+38%
Sales & marketing$9.4M$6.3M$3.1M+48%
General & admin$6.1M$4.5M$1.6M+35%
Operating cash sources$23.3M$6.6M$16.6M+250%
Depreciation & amortization$1.5M$845K$670K+79%
Share-based compensation$6.3M$4.5M$1.9M+41%
Working capital & other$15.4M$1.3M$14.1M12×
Net loss absorbed$14.1M$9.1M$4.9M+54%
Operating cash flow$9.2M−$2.5M$11.7M—

Questions

How much did Arteris's revenue grow year over year in Q2 2026?

Arteris's revenue rose $7.6M (+46%) from $16.5M in Q2 2025 to $24.1M in Q2 2026.

What drove Arteris's revenue change in Q2 2026?

Licensing, support and maintenance +$5.7M (+38%); Professional services and other +$1.2M (101×); Variable royalties +$701K (+50%).

Q2 2026 results → · Compare in the interactive Sankey →